Cardiac involvement in hypereosinophilia
Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Insights
Hypereosinophilia can cause rare cardiac diseases, progressing from inflammation to endomyocardial fibrosis. Identifying the cause of high eosinophil counts is crucial for treating these serious heart conditions.
Area of Science:
- Cardiology
- Hematology
Background:
- Hypereosinophilia can lead to rare cardiac abnormalities, often triggered by allergies or infections.
- Cardiac involvement progresses through three stages: inflammation, thrombosis, and irreversible endomyocardial fibrosis, a cause of restrictive cardiomyopathy.
Purpose of the Study:
- To summarize the pathophysiology, diagnosis, and management of cardiac abnormalities in hypereosinophilia.
- To highlight the importance of identifying the underlying cause for effective treatment.
Main Methods:
- Review of literature on hypereosinophilic cardiac disease.
- Discussion of diagnostic tools including echocardiography, cardiac MRI, PET-CT, and endomyocardial biopsy.
- Emphasis on blood eosinophil counts, though not always elevated initially.
Main Results:
- Cardiac involvement in hypereosinophilia is characterized by distinct stages.
- Diagnosis relies on a combination of clinical presentation, imaging, and biopsy.
- Elevated eosinophil levels are common but may be absent in early disease.
Conclusions:
- Early diagnosis and identification of the cause of hypereosinophilia are essential for managing cardiac complications.
- Treatment strategies depend on the underlying etiology of hypereosinophilia.
Abstract:
Cardiac abnormalities associated with hypereosinophilia represent rare diseases and occurs most commonly due to hypersensitivity or allergic reactions, other possible etiologies cover infections, malignancy, vasculitis or hypereosinophilic syndromes. Three stages of cardiac involvement are usually described. Initially, myocardial inflammation occurs, that can continue with a thrombotic stage and eventually progress to the last irreversible stage called endomyocardial fibrosis, which represents one of the acquired forms of restrictive cardiomyopathy. In most patients, increased levels of eosinophils in the blood differential test; however, it may not be present in the initial stages of the disease. Of the imaging methods, magnetic resonance imaging and positron emission tomography combined with CT PET-CT are used in addition to echocardiography. Endomyocardial biopsy may be indicated for definitive evidence of eosinophilic myocarditis. The clarification of the cause of hypereosinophilia is necessary for specific treatment of this disorder.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests

